BROWSE ALL ARTICLES BY TOPIC
Articles by Section - Regular Article
Listing articles 31 to 40 of 410
Meeting: ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior
With teenaged juvenile arthritis patients, it's important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them
Meeting: ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they're on immunosuppressive drugs
Meeting: ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Meeting: ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
Meeting: ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
Meeting: ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Features: A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
Meeting: ACR/ARHP Annual Meeting 2012: Rheumatology Professionals Turn Out by the Thousands
The American College of Rheumatology's (ACR) once-intimate annual gathering of rheumatologists has matured into a meeting for more than 12,000 professionals in the field
Meeting: ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules
Rheumatologists should develop a plan to keep in step with federal regulations
Meeting: ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?
Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit
